Whereas deletion or mutation of the gene encoding CYLD is a frequently occurring genomic aberration in multiple myeloma (MM), these events are extremely uncommon in DBLCL and MCL [26, 27]. This evidence concerns the gene CYLD and Miyoshi myopathy.